Sotalol: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Sources==" to "==References==") |
Neil.m.young (talk | contribs) (Text replacement - " ==" to "==") |
||
| Line 19: | Line 19: | ||
**Pediatric | **Pediatric | ||
== Indications == | == Indications== | ||
*Suppression of ventricular arrhythmias refractory to other meds | *Suppression of ventricular arrhythmias refractory to other meds | ||
*Suppression of SVT, a-fib | *Suppression of SVT, a-fib | ||
Revision as of 17:19, 6 July 2016
General
- Type: Beta blockers
- Dosage Forms:
- Common Trade Names:
Adult Dosing
- 80mg PO BID
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Indications
- Suppression of ventricular arrhythmias refractory to other meds
- Suppression of SVT, a-fib
Contraindications
- Allergy to class/drug
Adverse Reactions
- Hypotension, bradycardia
- Proarrhythmia (esp in patients with hypokalemia)
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
- Class II - Nonselective beta-blocker
- Class III effects (prolongs repol and refractoriness)
- Onset of action = 2-3hr
- Duration of action = 24hr